<--- Back to Details
First PageDocument Content
Pharmacology / Centre for Addiction and Mental Health / Antidepressant / Psychiatric medication / Pharmacogenomics / Antipsychotic / Mental disorder / David Healy / R. Michael Bagby / Psychiatry / Medicine / Health
Date: 2014-10-27 13:18:32
Pharmacology
Centre for Addiction and Mental Health
Antidepressant
Psychiatric medication
Pharmacogenomics
Antipsychotic
Mental disorder
David Healy
R. Michael Bagby
Psychiatry
Medicine
Health

Microsoft Word - James Kennedy OGI

Add to Reading List

Source URL: www.genomecanada.ca

Download Document from Source Website

File Size: 19,73 KB

Share Document on Facebook

Similar Documents

B A S I C S Basics of Pharmacogenomics

DocID: 1vjVD - View Document

Clinical pharmacology and Pharmacogenomics Challenges Patients respond highly variably to drug therapy. The reason may be pharmacokinetic and/or pharmacodynamic differences between patients, due to differences in metabol

DocID: 1uw1R - View Document

Emily Witt Pharmacogenomics of Depression Therapy HUMBIO 158G March 14, 2014

DocID: 1urEc - View Document

Emily  Doughty   BMI  258   Spring  2013   Final  Report     The  Future  of  Medicine:  Challenges  for  Pharmacogenomics  in  the  Clinic  

DocID: 1uhZc - View Document

Sydney Beache Human Biology 158G The Economic, Ethical, and Social Implications of the Pharmacogenomics Movement I. Introduction to Pharmacogenomics While the term “pharmacogenetics” has been in existence for roughly

DocID: 1u9i0 - View Document